AbbVie Other Non-Current Liabilities increased by 2.9% to $32.57B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $30.13B to $32.57B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 3.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Significant changes may reflect shifts in lease accounting, changes in employee benefit plans, or the emergence of long-term legal risks.
A catch-all category for long-term obligations that do not fall into major classifications like debt or deferred taxes....
Varies significantly by industry; companies with large physical retail footprints often show higher values here due to long-term leases.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.80B | $29.10B | $28.70B | $28.02B | $30.77B | $30.22B | $30.66B | $32.25B | $32.29B | $31.64B | $32.33B | $32.78B | $32.43B | $33.03B | $30.13B | $31.19B | $32.04B | $31.66B | $32.57B |
| QoQ Change | — | +1.0% | -1.4% | -2.4% | +9.8% | -1.8% | +1.5% | +5.2% | +0.1% | -2.0% | +2.2% | +1.4% | -1.1% | +1.9% | -8.8% | +3.5% | +2.7% | -1.2% | +2.9% |
| YoY Change | — | — | — | — | +6.8% | +3.8% | +6.8% | +15.1% | +5.0% | +4.7% | +5.5% | +1.6% | +0.4% | +4.4% | -6.8% | -4.8% | -1.2% | -4.2% | +8.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.